Van Allen, E. M., H. G. Golay, Y. Liu, S. Koyama, K. Wong, A. Taylor-Weiner, M. Giannakis, et al. 2015. “Long-Term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation.” Cancer Immunology Research 3 (8) (May 26): 855–863. doi:10.1158/2326-6066.cir-15-0024.